294 related articles for article (PubMed ID: 32905952)
1. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
[TBL] [Abstract][Full Text] [Related]
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
3. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
4. Hypermetabolic lesions of the pancreas on FDG PET/CT.
Dong A; Dong H; Zhang L; Zuo C
Clin Nucl Med; 2013 Sep; 38(9):e354-66. PubMed ID: 23486316
[TBL] [Abstract][Full Text] [Related]
5. Role of N-13 ammonia PET/CT in diagnosing pancreatic necrosis in patients with acute pancreatitis as compared to contrast enhanced CT--results of a pilot study.
Kashyap R; Mittal BR; Khaliq A; Manrai M; Appasani S; Bhattacharya A; Khandelwal N; Kochhar R
Pancreatology; 2014; 14(3):154-8. PubMed ID: 24854609
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Pancreatic Injury and Pancreatitis in Patients Treated With Immune Checkpoint Inhibitors.
Hori Y; Naitoh I; Naiki-Ito A; Kawai T; Yoshida M; Kato A; Kachi K; Sahashi H; Adachi A; Toyohara T; Kito Y; Yamamoto T; Takahashi S; Kataoka H
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00667. PubMed ID: 38088372
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune pancreatitis: imaging features.
Sahani DV; Kalva SP; Farrell J; Maher MM; Saini S; Mueller PR; Lauwers GY; Fernandez CD; Warshaw AL; Simeone JF
Radiology; 2004 Nov; 233(2):345-52. PubMed ID: 15459324
[TBL] [Abstract][Full Text] [Related]
9. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.
Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD
Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune pancreatitis: radiologic findings in 20 patients.
Yang DH; Kim KW; Kim TK; Park SH; Kim SH; Kim MH; Lee SK; Kim AY; Kim PN; Ha HK; Lee MG
Abdom Imaging; 2006; 31(1):94-102. PubMed ID: 16333694
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
Wachsmann JW; Ganti R; Peng F
Acad Radiol; 2017 Jan; 24(1):111-115. PubMed ID: 27818005
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
Kauhanen S; Rinta-Kiikka I; Kemppainen J; Grönroos J; Kajander S; Seppänen M; Alanen K; Gullichsen R; Nuutila P; Ovaska J
J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
[TBL] [Abstract][Full Text] [Related]
13. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
15. [Imaging features of autoimmune pancreatitis].
Cong GN; Qin MW; You H; Liu W; Xu K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):479-84. PubMed ID: 18795625
[TBL] [Abstract][Full Text] [Related]
16. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.
Shreve PD
Eur J Nucl Med; 1998 Mar; 25(3):259-64. PubMed ID: 9580859
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
18. Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT.
Das JP; Halpenny D; Do RK; Ulaner GA
Clin Nucl Med; 2019 Oct; 44(10):836-837. PubMed ID: 31283599
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
[TBL] [Abstract][Full Text] [Related]
20. Imaging diagnosis of post-ERCP focal pancreatitis mimicking pancreatic carcinoma by follow-up F-18 FDG PET/CT.
Jeong Yoon S; Lee B; Park CH
Clin Nucl Med; 2011 Jan; 36(1):70-2. PubMed ID: 21157219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
